Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kolopavivir + sofosbuvir for chronic hepatitis C (real-world, phase 4)
ChiCTR2400091967Phase 4Recruiting
- Sponsor
- Guangzhou Eighth People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of kolopavivir and sofosbuvir in hepatitis C virus infection, sponsored by Guangzhou Eighth People's Hospital. Primary endpoints: Liver function tests, HCV RNA viral load and 2 more. Started Nov 2024; status: recruiting.
02
Drugs
kolopavivirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ChiCTR2400091967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091967.